Cellular Therapeutics

Cellular Therapeutics was a UK-based biotechnology company specializing in the development of advanced cellular immunotherapies for the treatment of cancer. The company focused on Tumor Infiltrating Lymphocyte (TIL) technology, which involves harvesting a patient's own immune cells from a tumor, expanding them ex vivo, and re-infusing them to target and destroy cancer cells. Based in Manchester, the company established significant manufacturing capabilities and clinical programs targeting melanoma and other solid tumors. In 2020, the company was acquired by Instil Bio, which integrated its TIL pipeline and manufacturing infrastructure to accelerate the development of next-generation cell therapies.